financetom
Business
financetom
/
Business
/
Looking at re-pricing of protection products: SBI Life
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Looking at re-pricing of protection products: SBI Life
Oct 29, 2020 2:36 AM

SBI Life is looking at re-pricing of the protection products. Prices will be competitive and should come in this quarter, said Mahesh Kumar Sharma, MD and CEO of SBI Life.

The company’s Q2FY21 results were mostly in-line with expectations.

“Margins have increased from 18.1 percent to 18.8 percent,” Sharma said in an interview with CNBC-TV18.

“We have seen growth in the demand for insurance products. We will ensure that going forward we have a good growth in value of new business (VoNB) margins,” he added.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Vnet Group Q4 Loss Widens, Revenue Rises; 2024 Revenue Outlook Set
Vnet Group Q4 Loss Widens, Revenue Rises; 2024 Revenue Outlook Set
Mar 27, 2024
05:21 PM EDT, 03/27/2024 (MT Newswires) -- Vnet Group ( VNET ) reported a Q4 loss late Wednesday of 15.88 Chinese renminbi ($2.22) per American depositary share, wider than a loss of 0.42 renminbi a year earlier. One analyst surveyed by Capital IQ expected a loss of 1.29 renminbi. Revenue for the quarter ended Dec. 31 was 1.90 billion renminbi,...
Avalo Therapeutics Shares Triple After Acquisition of AlmataBio, Private Placement Financing of Up to $185 Million
Avalo Therapeutics Shares Triple After Acquisition of AlmataBio, Private Placement Financing of Up to $185 Million
Mar 27, 2024
05:26 PM EDT, 03/27/2024 (MT Newswires) -- Avalo Therapeutics ( AVTX ) shares more than tripled in after-hours trading Wednesday after the company said it acquired closely held AlmataBio and the phase 2-ready anti-IL-1beta mAb, or AVTX-009, to treat hidradenitis suppurativa, a severe autoimmune disease. Concurrently, the company said late Wednesday it entered into a definitive agreement to offer preferred...
Shoe Carnival Insider Sold Shares Worth $531,750, According to a Recent SEC Filing
Shoe Carnival Insider Sold Shares Worth $531,750, According to a Recent SEC Filing
Mar 27, 2024
05:21 PM EDT, 03/27/2024 (MT Newswires) -- Carl N. Scibetta, Senior Executive Vice President, Chief Merchandising Officer, on March 26, 2024, sold 15,000 shares in Shoe Carnival ( SCVL ) for $531,750. Following the Form 4 filing with the SEC, Scibetta has control over a total of 108,492 shares of the company, with 108,492 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/895447/000089544724000017/xslF345X03/edgardoc.xml...
Fedex Insider Sold Shares Worth $1,769,904, According to a Recent SEC Filing
Fedex Insider Sold Shares Worth $1,769,904, According to a Recent SEC Filing
Mar 27, 2024
05:21 PM EDT, 03/27/2024 (MT Newswires) -- Susan C Schwab, Director, on March 27, 2024, sold 6,145 shares in Fedex ( FDX ) for $1,769,904. Following the Form 4 filing with the SEC, Schwab has control over a total of 7,865 shares of the company, with 7,865 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1048911/000112760224011311/xslF345X03/form4.xml Price: 287.25, Change: -0.63, Percent Change: -0.22...
Copyright 2023-2026 - www.financetom.com All Rights Reserved